-
Gilead submits sNDA to FDA to expand HIV label for Descovy
pharmaceutical-technology
April 09, 2019
Gilead submits sNDA to FDA to expand HIV label for Descovy
-
Laurus Labs enters into strategic partnership agreement with Global Fund
expressbpd
March 27, 2019
Laurus Labs received a maiden TLD order and executed post the USFDA approval in February 2019
-
In hiking prices, drugmakers show some signs of tempering increases
PharmaSources/biopharmadive
March 26, 2019
In hiking prices, drugmakers show some signs of tempering increases
-
Glaxo's ViiV touts more two-drug HIV success with monthly injectable win
fiercepharma
March 11, 2019
GlaxoSmithKline’s ViiV Healthcare has already shown that a two-drug HIV regimen can hang with its three-drug competitors. But now it has data showing it can do the same with administration just once per month.
-
Second Man HIV-Free After Stem Cell Transplant
drugs
March 06, 2019
In only the second known case worldwide, a man is free of HIV after a stem cell transplant, doctors say.
-
FDA Grants Rolling Review for CytoDyn’s Planned BLA for Investigational HIV Therapy
americanpharmaceuticalreview
March 06, 2019
CytoDyn announced that the FDA has reviewed and accepted CytoDyn’s request and plan to submit on a rolling basis its planned Biologics License Application (BLA).
-
Combination therapy for coinfection with HIV and leishmaniasis
europeanpharmaceuticalreview
January 22, 2019
A combination of AmBisome monotherapy and miltefosine could be beneficial when treating a coinfection of HIV and visceral leishmaniasis…
-
Prescribed opioids raise risk of pneumonia
europeanpharmaceuticalreview
January 09, 2019
A study has found that opioids, including morphine, codeine and fentanyl increase the likelihood of patients being affected by pneumonia…
-
Can China’s R&D sector shake its reputational issues in 2019?
fiercebiotech
December 25, 2018
While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.Most notoriously, researcher Jiankui He caused a furor in November after.....
-
NIH to support HIV care and prevention research in the US
pharmaceutical-technology
December 14, 2018
The National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund human immunodeficiency virus (HIV) care ......